Loading
PDBj
✖
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

11RO

Crystal Structure of SARS-CoV-2 Mpro with UM-005

This is a non-PDB format compatible entry.
Summary for 11RO
Entry DOI10.2210/pdb11ro/pdb
Related PRD IDPRD_002602
Descriptor3C-like proteinase nsp5, N-(trifluoroacetyl)-D-phenylalanyl-N-{(1Z,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-phenylalaninamide (3 entities in total)
Functional Keywordsmpro, sars2, coronavirus, viral protease, main protease, viral protein
Biological sourceSevere acute respiratory syndrome coronavirus 2
Total number of polymer chains2
Total formula weight68196.65
Authors
Shaqra, A.M.,Adnan, S.F.Z.,Lee, L.T.,Iyer, V.,Jung, K.,Intravaia, L.E.,Kaur, J.,Schiffer, C.A. (deposition date: 2026-03-10, release date: 2026-04-22, Last modification date: 2026-10-07)
Primary citationBarasa, L.,Chen, Y.,Shaqra, A.M.,Adnan, S.F.Z.,Intravaia, L.E.,Huchaiah, S.,Allabaji, A.,S, K.K.,Vidadala, S.R.,Patil, S.N.,Hale, J.,Schiffer, C.A.,Fitzgerald, K.A.,Thompson, P.R.
Nitrile-Based Inhibitors Targeting both SARS-CoV‐2 Main Protease and Human Cathepsin L.
Acs Med.Chem.Lett., 17:1956-1965, 2026
Cited by
PubMed Abstract: The SARS-CoV-2 main protease (M) and host cysteine protease cathepsin L (CatL) are both attractive targets for antiviral intervention. Herein we describe the rational design and synthesis of dual M/CatL inhibitors derived from the previously reported leads and . Optimization focused on replacement of the acrylate ester warhead in and with a nitrile, modifying the P2, P3, and P4 capping groups, and variation of the P1 lactam ring size. In addition, conformational restriction was achieved through macrocyclization between the P1 and P4 side chains to enhance binding affinity. These efforts identified multiple dual-target inhibitors with nanomolar potency against both M and CatL and potent antiviral activity as well as selective M inhibitors with strong enzymatic activity. Targeting both a viral protease and a host factor may provide more durable antiviral efficacy by reducing susceptibility to resistance arising from viral evolution of M.
PubMed: 42741323
DOI: 10.1021/acsmedchemlett.6c00236
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.71 Å)
Structure validation

260626

PDB entries from 2026-10-07

PDB statisticsPDBj update infoContact PDBjnumon